Maryville Pharmacology Exam 1
Questions With Correct Answers
What are the 5 WHO prescribing guidelines? - CORRECT ANSWER✔✔-1.
| | | | | | | | | |
define the pt's problem
| | |
2. Specify therapeutic objectives
| | |
3. choose which drug or treatment is needed
| | | | | | |
4. Write the Rx and start tx
| | | | | |
5. Educate and counsel the pt
| | | | |
6. monitor effect of treatment
| | | |
WHO rx guideline 1 - CORRECT ANSWER✔✔-Define the pt's problem .
| | | | | | | | | | |
This forms the basis for choosing and rx-ing the correct treatment.
| | | | | | | | | | |
Consultation should include: complaints, symptoms, diagnosis and
| | | | | | |
relevant characteristics like co-morbidities, co-medication, pregnancy,
| | | | | |
drug allergies
|
WHO rx guideline 2 - CORRECT ANSWER✔✔-Specify the therapeutic
| | | | | | | | |
objective. What needs to be treated?
| | | | |
,WHO rx guideline 3 - CORRECT ANSWER✔✔-3a. select the p-drug
| | | | | | | | | |
(prescribers personal drug of first choice for the indication.)
| | | | | | | |
3b. Is the p-drug appropriate? checking for contraindications,
| | | | | | | |
interactions, pregnancy, allergies, etc. | | |
WHO rx guideline 4 - CORRECT ANSWER✔✔-Write rx and start the
| | | | | | | | | | |
treatment.
WHO rx guideline 5 - CORRECT ANSWER✔✔-Educate and counsel the
| | | | | | | | | |
pt. Intructions and warnings about the tx.
| | | | | |
WHO rx 6 - CORRECT ANSWER✔✔-Monitor the treatment.
| | | | | | |
Coreg (Carvedilol) - CORRECT ANSWER✔✔-*beta blocker used to treat
| | | | | | | | |
mild to severe CHF, left ventricular dysfunction following MI, HTN.
| | | | | | | | | |
*works by causing vasodilation to the peripheral vasculature to
| | | | | | | | |
decrease the workload on the heart.
| | | | | |
*Non selective beta blocker and Alpha-1 blocker
| | | | | |
*3rd generation beta blocker
| | |
*particularly useful in African Americans | | | |
*Dose: 0.625 mg-25mg PO BID with food
| | | | | |
*administering with food helps prevent postural hypotension | | | | | |
*Education: don't skip doses, take with food | | | | | |
, hypersensitivty reactions: mnemonic ACID - CORRECT ANSWER✔✔-1.
| | | | | | |
A-allergic
2.C-cytotoxic
3.I- Immune complex deposition
| | |
4. D-delayed
|
Type I hypersensitivity - CORRECT ANSWER✔✔-A-allergic
| | | | |
*IgE mediated- quick onset after exposure
| | | | |
*production of IgE after antigen exposure. | | | | | |
*urticaria, wheezing, rhinitis, anaphylaxis
| | |
Type II hypersensitivity - CORRECT ANSWER✔✔-C-cytotoxic
| | | | |
*cytotoxic/antibody mediated |
* drug binds to RBCs and is recognized by antibody-usually IgG
| | | | | | | | | |
*complement and cytotoxic T cells are activated | | | | | |
*Rare response |
Type III hypersensitivity - CORRECT ANSWER✔✔-I-immune
| | | | |
complex/IgG/IgM mediated
| |
*antibodies are formed against soluble antigens. ANtigen-antibody
| | | | | | |
complexes are deposited in tissues such as joints and lungs.
| | | | | | | | |
Questions With Correct Answers
What are the 5 WHO prescribing guidelines? - CORRECT ANSWER✔✔-1.
| | | | | | | | | |
define the pt's problem
| | |
2. Specify therapeutic objectives
| | |
3. choose which drug or treatment is needed
| | | | | | |
4. Write the Rx and start tx
| | | | | |
5. Educate and counsel the pt
| | | | |
6. monitor effect of treatment
| | | |
WHO rx guideline 1 - CORRECT ANSWER✔✔-Define the pt's problem .
| | | | | | | | | | |
This forms the basis for choosing and rx-ing the correct treatment.
| | | | | | | | | | |
Consultation should include: complaints, symptoms, diagnosis and
| | | | | | |
relevant characteristics like co-morbidities, co-medication, pregnancy,
| | | | | |
drug allergies
|
WHO rx guideline 2 - CORRECT ANSWER✔✔-Specify the therapeutic
| | | | | | | | |
objective. What needs to be treated?
| | | | |
,WHO rx guideline 3 - CORRECT ANSWER✔✔-3a. select the p-drug
| | | | | | | | | |
(prescribers personal drug of first choice for the indication.)
| | | | | | | |
3b. Is the p-drug appropriate? checking for contraindications,
| | | | | | | |
interactions, pregnancy, allergies, etc. | | |
WHO rx guideline 4 - CORRECT ANSWER✔✔-Write rx and start the
| | | | | | | | | | |
treatment.
WHO rx guideline 5 - CORRECT ANSWER✔✔-Educate and counsel the
| | | | | | | | | |
pt. Intructions and warnings about the tx.
| | | | | |
WHO rx 6 - CORRECT ANSWER✔✔-Monitor the treatment.
| | | | | | |
Coreg (Carvedilol) - CORRECT ANSWER✔✔-*beta blocker used to treat
| | | | | | | | |
mild to severe CHF, left ventricular dysfunction following MI, HTN.
| | | | | | | | | |
*works by causing vasodilation to the peripheral vasculature to
| | | | | | | | |
decrease the workload on the heart.
| | | | | |
*Non selective beta blocker and Alpha-1 blocker
| | | | | |
*3rd generation beta blocker
| | |
*particularly useful in African Americans | | | |
*Dose: 0.625 mg-25mg PO BID with food
| | | | | |
*administering with food helps prevent postural hypotension | | | | | |
*Education: don't skip doses, take with food | | | | | |
, hypersensitivty reactions: mnemonic ACID - CORRECT ANSWER✔✔-1.
| | | | | | |
A-allergic
2.C-cytotoxic
3.I- Immune complex deposition
| | |
4. D-delayed
|
Type I hypersensitivity - CORRECT ANSWER✔✔-A-allergic
| | | | |
*IgE mediated- quick onset after exposure
| | | | |
*production of IgE after antigen exposure. | | | | | |
*urticaria, wheezing, rhinitis, anaphylaxis
| | |
Type II hypersensitivity - CORRECT ANSWER✔✔-C-cytotoxic
| | | | |
*cytotoxic/antibody mediated |
* drug binds to RBCs and is recognized by antibody-usually IgG
| | | | | | | | | |
*complement and cytotoxic T cells are activated | | | | | |
*Rare response |
Type III hypersensitivity - CORRECT ANSWER✔✔-I-immune
| | | | |
complex/IgG/IgM mediated
| |
*antibodies are formed against soluble antigens. ANtigen-antibody
| | | | | | |
complexes are deposited in tissues such as joints and lungs.
| | | | | | | | |
